Slide 1 ASCO 2009 Highlights in Gastrointestinal Malignancies Axel Grothey Professor of Oncology Mayo Clinic Rochester Axel Grothey Professor of Oncology Mayo Clinic Rochester…

Slide 1 Open to Options: Training Cancer Research Staff to Enhance Clinical Trials Access Margo Michaels, Natasha Blakeney, Melissa Miller, Kathleen Coyne, Bonnie Crawford,…

Inclusion Criteria Patient has definitive histologically or cytologically confirmed metastatic adenocarcinoma of the pancreas. The definitive diagnosis of metastatic pancreatic…

I Canât Believe Itâs Not JEOPARDY! I Canât Believe Itâs Not JEOPARDY! 100 What is the purpose of clinical trials? To ask specific scientific questions to find better…

Uterine Cancers A. Alobaid, MBBS, FRCS(C), FACOG Consultant, Gynecologic Oncology Assistant professor, KSU Medical Director, Womenâs Specialized Hospital King Fahad Medical…

Herceptin® adjuvant therapy: “a triumphal narrative of translational research” Brian Leyland-Jones McGill University Department of Oncology Montreal, Quebec, Canada…

Is targeted therapy ready for the adjuvant setting ? Emile E. Voest Department of Medical Oncology UMC Utrecht “Failure to appreciate the problems surrounding the assessment…

Current Considerations in the Management of Patients with Hormonally Sensitive Early-stage Breast Cancer Harold J. Burstein, MD, PhD Dana-Farber Cancer Institute Harvard…

2013;3:751-760. Published OnlineFirst April 23, 2013.Cancer Discovery Henok Eyob, Huseyin Atakan Ekiz, Yoko S. DeRose, et al. Overt Metastases by Boosting Antitumor Immunity…

INNOVAZIONI TERAPEUTICHE IN ONCOLOGIA MEDICA CAGLIARI 23-24 GIUGNO 2005 LE TERAPIE A TARGET MOLECOLARE: UNA EVOLUZIONE EPOCALE DELLA TERAPIA ANTINEOPLASTICA GIOVANNI MANTOVANI…